Published in

Nature Research, Scientific Reports, 1(4), 2014

DOI: 10.1038/srep03618

Links

Tools

Export citation

Search in Google Scholar

The antimalarial drug quinine interferes with serotonin biosynthesis and action

Journal article published in 2014 by Farida Islahudin, Sarah M. Tindall, Ian R. Mellor, Karen Swift, Hans E. M. Christensen, Kevin C. F. Fone, Richard J. Pleass, Kang-Nee Ting, Simon V. Avery ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Red circle
Postprint: archiving forbidden
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO

Abstract

AbstractThe major antimalarial drug quinine perturbs uptake of the essential amino acid tryptophan and patients with low plasma tryptophan are predisposed to adverse quinine reactions; symptoms of which are similar to indications of tryptophan depletion. As tryptophan is a precursor of the neurotransmitter serotonin (5-HT), here we test the hypothesis that quinine disrupts serotonin function. Quinine inhibited serotonin-induced proliferation of yeast as well as human (SHSY5Y) cells. One possible cause of this effect is through inhibition of 5-HT receptor activation by quinine, as we observed here. Furthermore, cells exhibited marked decreases in serotonin production during incubation with quinine. By assaying activity and kinetics of the rate-limiting enzyme for serotonin biosynthesis, tryptophan hydroxylase (TPH2), we showed that quinine competitively inhibits TPH2 in the presence of the substrate tryptophan. The study shows that quinine disrupts both serotonin biosynthesis and function, giving important new insight to the action of quinine on mammalian cells.